[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621765":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":34,"collaborators":10,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":10,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":10,"enrollmentInfo":45,"targetDuration":10,"studyType":48,"phases":10,"briefSummary":49,"conditions":50,"keywords":10,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Institute of Hematology & Blood Diseases Hospital, China","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Adult patients receiving HLA-haploidentical transplants",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Yahui Feng","CONTACT","022-23608045","fengyahui@ihcams.ac.cn",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Institute of Hematology & Blood Diseases Hospital","RECRUITING","Tianjin","Tianjin Municipality","300000","China","CN",{"type":27,"coordinates":28},"Point",[29,30],117.17667,39.14222,{"lat":30,"lon":29},[33],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100621765","a-cohort-study-on-the-association-between-the-ans-function-and-acute-gvhd-100621765",false,"NCT07374874","A Cohort Study on the Association Between the ANS Function and Acute GvHD","A Cohort Study on the Association Between the Autonomic Nervous System Function and Acute GvHD After Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation","Inclusion Criteria:\n\n1. Patients must be \\> 16 years of age;\n2. Patients receiving HLA-haploidentical transplants;\n3. Patients have to sign an informed consent form before the start of the research procedure.\n\nExclusion Criteria:\n\n1. Tandem transplantation or multiple transplantations;\n2. Mental or other medical conditions that make the patients unable to comply with the research treatment and monitoring requirements;\n3. Patients who are ineligible for the study due to other factors, or will bear great risk if participating in the study.","ALL","16 Years",{"count":46,"type":47},60,"ESTIMATED","OBSERVATIONAL","This is a prospective observational study. The investigators plan to utilize this model as a tool for early classification and interrogate ANS function of transplant recipients.",[51],"Transplant-Related Disorder","2026-01-23",{"date":54,"type":55},"2026-01-29","ACTUAL",{"date":57,"type":55},"2025-12-18",{"date":59,"type":47},"2027-01-01",{"name":5,"class":6},1]